Molecular and geographical heterogeneity of hemoglobinopathy mutations in Azerbaijanian populations

2019 ◽  
Vol 84 (3) ◽  
pp. 249-258 ◽  
Author(s):  
Gunay Aliyeva ◽  
Chingiz Asadov ◽  
Tahira Mammadova ◽  
Surmaya Gafarova ◽  
Yegana Guliyeva ◽  
...  
2005 ◽  
Vol 34 (4) ◽  
pp. 204-208 ◽  
Author(s):  
M. Carrozzo ◽  
F. Brancatello ◽  
E. Dametto ◽  
P. Arduino ◽  
M. Pentenero ◽  
...  

2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Day-Yu Chao ◽  
Kuang-Fu Cheng ◽  
Ying-Hen Hsieh ◽  
Tsai-Chung Li ◽  
Trong-Neng Wu ◽  
...  

2013 ◽  
Vol 7 (12) ◽  
pp. e2608 ◽  
Author(s):  
Lynn Meurs ◽  
Moustapha Mbow ◽  
Nele Boon ◽  
Frederik van den Broeck ◽  
Kim Vereecken ◽  
...  

2015 ◽  
Vol 3 (1) ◽  
Author(s):  
A. Amphlett

Abstract Far East scarlet-like fever (FESLF) is a severe inflammatory disease that occurs sporadically and in outbreaks in Russia and Japan. Far East scarlet-like fever is caused by Yersinia pseudotubuclosis infection, an organism that typically causes self-limiting gastroenteritis in Europe. Studies suggest the ability of Far Eastern strains to produce superantigen toxin Y pseudotuberculosis-derived mitogen A is integral to FESLF pathogenesis. In Europe, human Y pseudotuberculosis infection typically occurs sporadically, in the form of a self-limiting gastroenteritis. In Russia and Japan, outbreaks of Y pseudotuberculosis infection cause severe systemic inflammatory symptoms. This disease variant is called FESLF. Geographical heterogeneity exists between virulence factors produced by European and Far Eastern Y pseudotuberculosis strains, implicating superantigen Y pseudotuberculosis-derived mitogen A (YPMa) in the pathogenesis of FESLF. This article describes the epidemiology and clinical features of FESLF, and it presents the evidence for the role of YPMa in FESLF pathogenesis.


2018 ◽  
Vol 27 ◽  
pp. 29-35 ◽  
Author(s):  
O. Amram ◽  
J. Shoveller ◽  
R. Hogg ◽  
L. Wang ◽  
P. Sereda ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document